Related references
Note: Only part of the references are listed.The pharmacology of statins
Cesare R. Sirtori
PHARMACOLOGICAL RESEARCH (2014)
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study
Paul Kah Hing Ling et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study)
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Safety and Efficacy of Ezetimibe/Simvastatin Combination Versus Atorvastatin Alone in Adults ≥65 Years of Age With Hypercholesterolemia and With or at Moderately High/High Risk for Coronary Heart Disease (the VYTELD Study)
JoAnne M. Foody et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients
Maurizio Averna et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)
Jennifer G. Robinson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study
M. Farnier et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease
Scott E. Conard et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Heart Disease
Lawrence A. Leiter et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial
Mohammad Zubaid et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2008)
Low-density lipoprotein cholesterol reduction: The end is more important than the means
John C. LaRosa
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy
Matthew Silva et al.
CLINICAL THERAPEUTICS (2007)
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients
Alberico L. Catapano et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe
SS Daskalopoulou et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease
V Barrios et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease
M Farnier et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease
JM Cruz-Fernández et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Prevention and Rehabilitation - Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
CM Ballantyne et al.
AMERICAN HEART JOURNAL (2005)
Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, double-blind, placebo-controlled trial
AC Goldberg et al.
MAYO CLINIC PROCEEDINGS (2004)
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia
MH Davidson et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals
T Feldman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
HE Bays et al.
CLINICAL THERAPEUTICS (2004)
Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor
L Jeu et al.
CLINICAL THERAPEUTICS (2003)
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial
CM Ballantyne et al.
CIRCULATION (2003)
Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial
L Melani et al.
EUROPEAN HEART JOURNAL (2003)
Efficacy and safety of Ezetimibe coadministered with Lovastatin in primary hypercholesterolemia
B Kerzner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
HMG-Co A reductase inhibitors in the treatment of cardiovascular diseases: Stabilization of coronary artery plaque
R Morishita et al.
CURRENT DRUG TARGETS (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Share Paper
